Wikidata entity: Q415996
C₂₀H₂₁F₃N₄O (P274)
Quantities
| P2067 | mass | 390.167 |
| P3780 | active ingredient in | ... | Q47520880 (Addyi) | Addyi |
| P233 | canonical SMILES | String | C1CN(CCN1CCN2C3=CC=CC=C3NC2=O)C4=CC=CC(=C4)C(F)(F)F | ??? |
| P373 | Commons category | String | Flibanserin | ??? |
| P366 | has use | ... | Q12140 (medication) | medication |
| P8224 | image of molecular model or crystal lattice model | CommonsMedia | http://commons.wikimedia.org/wiki/Special:FilePath/Flibanserin%20ball-and-stick%20model.png | ??? |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P3493 | legal status (medicine) | ... | Q879952 (boxed warning) | boxed warning |
| P8026 | LiverTox likelihood score | ... | Q83284878 (Լյարդի ախտահարման հավանականության E կատեգորիա) | Լյարդի ախտահարման հավանականության E կատեգորիա |
| P129 | physically interacts with | ... | Q1949517 (5-hydroxytryptamine receptor 2A) | 5-hydroxytryptamine receptor 2A |
| P129 | physically interacts with | ... | Q21115043 (5-hydroxytryptamine receptor 1A) | 5-hydroxytryptamine receptor 1A |
| P3489 | pregnancy category | ... | Q28123617 (US pregnancy category C) | US pregnancy category C |
| P279 | subclass of | ... | Q193430 (heterocyclic compound) | heterocyclic compound |
| P2868 | subject has role | ... | Q50348938 (xenobiotic-transporting ATPase inhibitor) | xenobiotic-transporting ATPase inhibitor |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | flibanserin | ??? |
Why not click here or view trends?
log id: None